Taaleri’s first bioindustry fund invests in Nordtreat, a company producing bio-based flame retardants

Taaleri’s first bioindustry fund invests in Nordtreat, a Finnish company producing bio-based, environmentally friendly and non-harmful flame-retardants. The purpose of the investment is to strengthen Nordtreat's growth and expansion.

Founded in 2015, Nordtreat manufactures bio-based flame-retardant chemicals for building materials made from renewable raw materials. The company has developed and commercialized fire retardants, especially for wood construction. The products are based on the company's patented fire protection technology. Nordtreat's products replace traditional flame-retardants that contain compounds that are harmful to humans and the environment, such as boric acid, formaldehyde, and ammonia.

The investment is Taaleri Bioindustry I Fund’s second investment. The fund invests in industrial-scale production facilities and companies that can accelerate the scaling of bioindustry production. Products can be, for example, bio- and recycled fibers, organic fertilizers, functional biomaterials, and recycled materials to replace virgin products.

Taaleri Bioindustry I Fund complies with Article 9 of the EU Sustainable Finance Disclosure Regulation and is as such a so called dark green fund that only makes sustainable investments in projects that, for example, contribute substantially to climate change mitigation. The fund has raised over EUR 100 million and continues fundraising. The state-owned special-assignment companyFinnish Climate Fund is the fund’s anchor investor.

In February 2022, Taaleri made an investment of one million euros in Nordtreat from its own balance sheet. This investment will be acquired by the fund in addition to the investment made now.

“We are very happy to continue our partnership with Nordtreat. We see great potential for the company’s international growth. We believe that the demand for sustainable fire retardants will grow in the international building product industry, as the responsibility requirements of developers become stricter”, says Tero Saarno, Director of Taaleri Bioindustry.

“Taaleri Bioindustry I Fund’s investment enables the scaling of production and supply of Nordtreat’s bio-based flame-retardant technology to a growing industrial customer base globally. In the past twelve months, we have been able to accelerate the commercialisation of our technology to two new industrial segments, cellulose insulation and kraft paper, as well as solidifying our position as a preferred supplier for flame-retardant solutions for the wood industry through Taaleri’s previous investment,” says Aki Borgentrop, CEO of Nordtreat.

Taaleri's vision is to be a Nordic pioneer in alternative investments focusing on sustainability. We use capital and our expertise to build a better future, and in addition to bioindustry projects, we promote e.g. wind and solar power.

For further information, please contact:
Tero Saarno, director, Taaleri Bioindustry, +358 50 373 1923, tero.saarno@taaleri.com
Aki Borgentrop, CEO, Nordtreat, +358 400 366 801

Taaleri in brief

Taaleri is a Nordic investment and asset manager with an emphasis on renewable energy and other alternative investments. We channel capital towards economically profitable undertakings that have a lasting positive impact on the environment and society. We combine capital with talent, expertise, entrepreneurship, and a bold sense of purpose. We are a signatory of the UN Principles for Responsible Investment (UNPRI) since 2010, and we joined the Net Zero Asset Managers initiative in 2021. Taaleri’s vision is to be a Nordic forerunner in alternative investments focusing on sustainability.

Taaleri has two business segments: Private Asset Management and Strategic Investments. Private Asset Management consists of renewable energy, real estate and bioindustry businesses. The Strategic Investments segment includes Garantia Insurance Company Ltd.

Taaleri has EUR 2.5 bn of assets under management in its private equity funds and co-investments. The company has approximately 120 employees. Taaleri Plc is listed on Nasdaq Helsinki.


Nordtreat in brief

Nordtreat is growth company in the chemicals industry founded in 2015. The company is specialised in manufacturing of bio-based environmentally friendly flame-retardants. Nordtreat’s patented technology is utilised in fire protection of sustainable construction products, especially in public and apartment buildings.

The company employs more than 30 people in Finland, France, Germany, Netherlands, Poland and Sweden, and operates its own production facility in Vantaa.


« Back to: News Room

Taaleri’s first bioindustry fund invests in Colombier, a company producing ecological packaging
Taaleri’s bioindustry fund invests in Nordic Bioproducts Group, a company producing cellulose-based materials with a high processing value